Kronox Lab Sciences Limited (NSE:KRONOX)

Market Cap	7.35B +28.7%
Revenue (ttm)	1.05B +6.1%
Net Income	286.84M +12.1%
EPS	7.81 +13.3%
Shares Out	37.10M
PE Ratio	25.35
Forward PE	n/a
Dividend	0.50 (0.25%)
Ex-Dividend Date	Sep 9, 2026

Volume	31,405
Open	190.00
Previous Close	190.49
Day's Range	181.06 - 200.01
52-Week Range	96.00 - 227.74
Beta	0.89
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About Kronox Lab Sciences

Kronox Lab Sciences Limited manufactures and sells fine chemicals, inorganic chemicals, phosphates, and metallic chemicals in India and internationally. The company provides bulk reagents comprising ACS reagents, as well as LR, AR, and GR reagents; bulk ingredients that includes oral care, pharmacopoeia, food and nutraceutical, personal care and cosmetics, and veterinary pharma and animal health; and specialty chemicals, such as tartrates, citrates, hypophosphites, phosphates, hydroxides, EDTA and derivatives, ultra high purity chemicals, and c...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 2008
• Employees: 54
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: KRONOX

Financial Performance

In fiscal year 2026, Kronox Lab Sciences's revenue was 1.01 billion, an increase of 1.02% compared to the previous year's 1.00 billion. Earnings were 276.60 million, an increase of 8.61%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 22, 2026

Data Sources Report a data error